Investment funds
A cataract operation? Done in a flash!
Medical technology
If we think about our grandparents and what an intervention like the one we mentioned would have meant, we will be able to realise and value the full magnitude of the importance of technology in the development of medicine in the last 50 years. Technological advances that we recognise not only in surgery, but also in the diagnosis, development and subsequent treatment of diseases.
-
The evolution of emerging societies.It increasingly demands healthier and more ecologically sustainable products.
-
The ageing of the population and the increase in life expectancy.The older the people, the more health care that is needed and for more years. These two factors are of particular relevance for the growth of healthcare technology.
-
Collaboration with other technologies in constant development.Medical technology collaborates with other technological areas that have experienced tremendous growth in recent years, such as smartphones and big data.
The recent saturation of health systems has highlighted the need for greater investment in the health sector to enable the generation of true economic and social growth in countries
A healthier population is a more economically active population. A determining factor for governments and companies capable of recognising a great ally in medical technology:
-
Development of new devices for early diagnosis.The importance of early diagnosis of some diseases, such as cancer, significantly improves their treatment and recovery time.
-
Greater accessibility to medical appointments through telemedicine.Thanks to technology, we can have remote medical care, with the direct benefit of reducing waiting lists, optimising doctor-patient time and, in the case of the elderly, that of their relatives.
-
Improvement of the quality of life of chronic patients.Examples such as diabetes patients who can more easily and accurately control their blood glucose levels or dependant patients who, thanks to hyperconnectivity with their family members, can enjoy a life closer to normality.
-
New instruments and techniques capable of drastically reducing the mortality rate of some diseases.As in the treatment of cardiovascular diseases that, thanks to artificial tubes, has seen the number of deaths reduced by more than half.
Evolution of spending in the health sector.
Source: Statista
Our investment universe covers the entire health sector, with the exception of medicines.
- Companies that apply the progress of new technologies to health in all stages of the disease, from the diagnosis of the disease to possible rehabilitation.
- Investment focused primarily on the cardiology subsector, managed care, and life sciences supply.
- It includes companies engaged in the production of devices and both medical and surgical procedures used in health care.
What do the experts think?
- Even in the case of equities, the sector has a low correlation with the rest of the market, which allows for diversification.
Our investment proposal
The value of investment funds1 can fall as well as rise, and you may get back less than you invested.
LU0415391431
BELLEVUE MEDTECH & SERVICES
High
EUR
1000 €
ES0113573002
BANKINTER PLATEA MEGATENDENCIAS
Medium/High
EUR
10 €
Access your private area to continue arranging the fund.
Go to y account
Call us on 900 816 833 and we'll explain how to arrange this fund.
- SEE SUMMARY IN SPANISH OF THE RIGHTS OF INVESTORS IN THE BELLEVUE MEDTECH & SERVICES FUND
- SEE SUMMARY IN SPANISH OF THE RIGHTS OF INVESTORS IN THE BANKINTER PLATEA MEGATENDENCIAS FUND
-
Show/Hide legal text1 Investment funds: The key investor information document, prospectus and all other legal documents related to Bankinter's collective investment institutions are available at any of our branches, on the Bankinter website (www.bankinter.com) and on the website of the Spanish National Securities Market Commission (CNMV) (www.cnmv.es).
-
Show/Hide legal textThe Key Investor Information Document and the prospectus are available on the website of the investment managersw: Bankinter.com; Waystone – Services to the Asset Management Industry.
For more information about this product, please refer to the website of the investment managers: Bankinter.com; Waystone – Services to the Asset Management Industry. -
Show/Hide legal textThis is an advertising communication. Please refer to the UCITS prospectus and key investor information document before making a final investment decision. The fund managers may decide to stop marketing the funds in the situations provided for in applicable legislation, in accordance with Article 93a of Directive 2009/65/EC and Article 32a of Directive 2011/61/EU.
-
Show/Hide legal textThe BELLEVUE MEDTECH & SERVICES fund is a sub-fund of Bellevue Funds authorised in Luxembourg, regulated by the Commissión de Surveillance du Secteur Financier (CSSF) and registered with the CNMV under number 938.
-
Show/Hide legal textThe BANKINTER PLATEA MEGATENDENCIAS fund is a fund from Bankinter Gestión de Activos, S.A., SGIIC authorised in Spain and regulated by the CNMV, with which it is registered as number 5408.
-
Show/Hide legal textThe CIS promotes environmental, social and governance (ESG) criteria under Article 8 of Regulation (EU) 2019/2088 on the disclosure of information related to sustainability in the financial services sector, also known by the English acronym SFDR, and is subject to sustainability risk, as defined in the risk profile. Decisions to invest in this fund must consider all of the characteristics and objectives of the fund.
-
Show/Hide legal textSee information on aspects related to sustainability: Environmental, social and corporate governance - Waystone; Sustainability Plan | Bankinter Corporate Website.